These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8860737)

  • 1. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
    Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
    Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract.
    Stewart GD; Bariol SV; Grigor KM; Tolley DA; McNeill SA
    BJU Int; 2005 Apr; 95(6):791-3. PubMed ID: 15794784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
    Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of human E-cadherin (ECD) correlated with invasiveness of transitional cell cancer in the renal pelvis, ureter and urinary bladder.
    Wakatsuki S; Watanabe R; Saito K; Saito T; Katagiri A; Sato S; Tomita Y
    Cancer Lett; 1996 May; 103(1):11-7. PubMed ID: 8616803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
    Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
    Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of nucleolar organizer regions in human bladder cancers by light- and electron-microscopic morphometry.
    Shimazui T; Uchiyama Y; Uchida K; Hattori K; Takahashi A; Akaza H; Koiso K
    Eur Urol; 1998; 34(5):441-7. PubMed ID: 9803008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological characteristics of inverted papilloma of the urinary bladder.
    Urakami S; Igawa M; Shirakawa H; Shiina H; Ishibe T
    Br J Urol; 1996 Jan; 77(1):55-60. PubMed ID: 8653317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar organizer regions in bladder cancer: application to urinary cytology.
    Masuda M; Nagamoto A; Hirokawa M; Takano Y; Shuin T
    Urology; 1994 Aug; 44(2):194-8. PubMed ID: 8048194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
    Celikel C; Dillioğlugil O; Türkeri LN; Başaran M; Yalçiner A; Küllü S; Akdaş A
    Eur Urol; 1995; 28(2):152-7. PubMed ID: 8529742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
    Akpolat I; Bariş YS; Yilmaz AF; Bakirtaş M; Saylik A; Karagöz F; Kandemir B
    Neoplasma; 1998; 45(6):365-8. PubMed ID: 10210109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
    Helpap B; Loesevitz L; Bulatko A
    Virchows Arch; 1994; 425(3):265-9. PubMed ID: 7812512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of carcinoma in situ and high 2C-deviation index are the best predictors of invasive transitional cell carcinoma of the bladder in patients with high-risk Quanticyt.
    van Rhijn BW; van der Poel HG; Boon ME; Debruyne FM; Schalken JA; Witjes JA
    Urology; 2000 Mar; 55(3):363-7. PubMed ID: 10699611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
    Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
    Micron; 2007; 38(6):674-9. PubMed ID: 17011198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
    Hansen AB; Bjerregaard B; Ovesen H; Horn T
    Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.